| Metric | Q2 2021 | Q1 2021 | Q2 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.1B | 0.4% | 2.2% |
| Op. Income | $330M | $294M | -$306M | 12.4% | 208.0% |
| Gross Margin | 76.5% | 68.8% | 15.9% | 7.7pp | 60.6pp |
| Net Margin | 17.4% | 16.5% | -15.8% | 0.9pp | 33.2pp |
| EPS (Diluted) | $2.54 | $2.40 | $-2.25 | 5.8% | 212.9% |
| Free Cash Flow | $261M | $175M | $16M | 48.9% | 1490.1% |
| Item | Amount |
|---|---|
| REVENUE | $1.2B |
| Cost of Revenue | $274M |
| GROSS PROFIT | $890M |
| R&D Expenses | $0 |
| Selling & Marketing | $30M |
| General & Administrative | $364M |
| SG&A Expenses | $395M |
| Other Expenses | $165M |
| Operating Expenses | $560M |
| Cost & Expenses | $834M |
| OPERATING INCOME | $330M |
| Interest Income | $834M |
| Interest Expense | $169M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $330M |
| Income Tax Expense | $123M |
| NET INCOME | $203M |
| D&A | $47M |
| EBIT | $330M |
| EBITDA | $378M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| REVENUE | $1.2B |
| Cost of Revenue | $274M |
| GROSS PROFIT | $890M |
| R&D Expenses | $0 |
| Selling & Marketing | $30M |
| General & Administrative | $364M |
| SG&A Expenses | $395M |
| Other Expenses | $165M |
| Operating Expenses | $560M |
| Cost & Expenses | $834M |
| OPERATING INCOME | $330M |
| Interest Income | $834M |
| Interest Expense | $169M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $330M |
| Income Tax Expense | $123M |
| NET INCOME | $203M |
| D&A | $47M |
| EBIT | $330M |
| EBITDA | $378M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| Net Income | $203M |
| Depreciation & Amortization | $47M |
| Stock-Based Compensation | $6M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$102M |
| Change in Working Capital | $111M |
| OPERATING CASH FLOW | $265M |
| Capital Expenditure | -$5M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $1.2B |
| NET CASH FROM INVESTING | $1.2B |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$1.8B |
| NET CASH FROM FINANCING | -$1.8B |
| FREE CASH FLOW | $261M |
| Net Change in Cash | -$360M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $11.0B |
| Short-Term Investments | $11.7B |
| Net Receivables | $302M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $23.0B |
| PP&E (Net) | $563M |
| Goodwill | $236M |
| Intangible Assets | $531M |
| Long-Term Investments | $46.1B |
| Tax Assets | $0 |
| Other Non-Current Assets | $585M |
| TOTAL NON-CURRENT ASSETS | $48.0B |
| TOTAL ASSETS | $71.0B |
| Account Payables | $92M |
| Short-Term Debt | $7.5B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $43.3B |
| TOTAL CURRENT LIABILITIES | $50.9B |
| Long-Term Debt | $6.7B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $5.9B |
| TOTAL NON-CURRENT LIABILITIES | $12.7B |
| TOTAL LIABILITIES | $63.6B |
| Common Stock | $382M |
| Additional Paid-In Capital | $65M |
| Retained Earnings | $387M |
| Treasury Stock | -$60M |
| Accum. Other Comp. Income | $196M |
| Other Equity | $6.3B |
| TOTAL STOCKHOLDERS' EQUITY | $7.3B |
| Minority Interest | $146M |
| TOTAL EQUITY | $7.4B |
| TOTAL LIABILITIES & EQUITY | $71.0B |
| Total Debt | $14.2B |
| Net Debt | $3.2B |
